155 related articles for article (PubMed ID: 38638638)
1. Case report: Severe hepatopathy following rivaroxaban administration in a dog.
Mosichuk AP; Wimbish C; Poplawski K; Birkenheuer A; Harrell K; Pierce KV
Front Vet Sci; 2024; 11():1364677. PubMed ID: 38638638
[TBL] [Abstract][Full Text] [Related]
2. Suspected hepatotoxicity secondary to trazodone therapy in a dog.
Arnold A; Davis A; Wismer T; Lee JA
J Vet Emerg Crit Care (San Antonio); 2021 Jan; 31(1):112-116. PubMed ID: 33378129
[TBL] [Abstract][Full Text] [Related]
3. The use of rivaroxaban for the treatment of thrombotic complications in four dogs.
Yang VK; Cunningham SM; Rush JE; de Laforcade A
J Vet Emerg Crit Care (San Antonio); 2016 Sep; 26(5):729-36. PubMed ID: 26990131
[TBL] [Abstract][Full Text] [Related]
4. Rivaroxaban-induced hepatotoxicity: review of the literature and report of new cases.
Licata A; Puccia F; Lombardo V; Serruto A; Minissale MG; Morreale I; Giannitrapani L; Soresi M; Montalto G; Almasio PL
Eur J Gastroenterol Hepatol; 2018 Feb; 30(2):226-232. PubMed ID: 29120909
[TBL] [Abstract][Full Text] [Related]
5. Use of apixaban after development of suspected rivaroxaban-induced hepatic steatosis; a case report.
Anastasia EJ; Rosenstein RS; Bergsman JA; Parra D
Blood Coagul Fibrinolysis; 2015 Sep; 26(6):699-702. PubMed ID: 26154612
[TBL] [Abstract][Full Text] [Related]
6. Possible drug-induced hepatopathy in a dog receiving zonisamide monotherapy for treatment of cryptogenic epilepsy.
Schwartz M; Muñana KR; Olby NJ
J Vet Med Sci; 2011 Nov; 73(11):1505-8. PubMed ID: 21720107
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and posttreatment monitoring of dogs administered rivaroxaban (2018-2020): 19 cases.
Tracy AL; Goggs R; Brooks MB; Lynch AM
J Vet Emerg Crit Care (San Antonio); 2022 Sep; 32(5):629-636. PubMed ID: 35442563
[TBL] [Abstract][Full Text] [Related]
8. The influence of feeding and gastroprotectant medications on the Factor Xa inhibitory activity of orally administered rivaroxaban in normal dogs.
Lynch AM; Ruterbories LK; Griffith E; Hanel RM; Stablein AP; Brooks MB
J Vet Emerg Crit Care (San Antonio); 2021 Jan; 31(1):59-65. PubMed ID: 33107158
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulant activity of oral rivaroxaban in healthy dogs.
Conversy B; Blais MC; Dunn M; Gara-Boivin C; Del Castillo JRE
Vet J; 2017 May; 223():5-11. PubMed ID: 28671072
[TBL] [Abstract][Full Text] [Related]
10. Successful management of portal vein thrombosis in a Yorkshire Terrier with protein-losing enteropathy.
Sakamoto Y; Ishigaki K; Ishikawa C; Nakayama T; Asano K; Sakai M
BMC Vet Res; 2020 Nov; 16(1):418. PubMed ID: 33138806
[TBL] [Abstract][Full Text] [Related]
11. Rivaroxaban postmarketing risk of liver injury.
Russmann S; Niedrig DF; Budmiger M; Schmidt C; Stieger B; Hürlimann S; Kullak-Ublick GA
J Hepatol; 2014 Aug; 61(2):293-300. PubMed ID: 24681117
[TBL] [Abstract][Full Text] [Related]
12. Arterial thrombosis after vehicular trauma and humeral fracture in a dog.
DePaula KM; deLaorcade AM; King RG; Hughs H; Boudrieau RJ
J Am Vet Med Assoc; 2013 Aug; 243(3):394-8. PubMed ID: 23865882
[TBL] [Abstract][Full Text] [Related]
13. Aflatoxicosis in nine dogs after exposure to contaminated commercial dog food.
Newman SJ; Smith JR; Stenske KA; Newman LB; Dunlap JR; Imerman PM; Kirk CA
J Vet Diagn Invest; 2007 Mar; 19(2):168-75. PubMed ID: 17402611
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic monitoring of rivaroxaban in dogs using thromboelastography and prothrombin time.
Bae J; Kim H; Kim W; Kim S; Park J; Jung DI; Yu D
J Vet Intern Med; 2019 May; 33(3):1322-1330. PubMed ID: 30859645
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of point-of-care coagulation tests as alternatives to anti-Xa activity for monitoring the anticoagulant effects of rivaroxaban in healthy dogs.
Lynch AM; Ruterbories LK; Griffith EH; Hanel RM; Stablein AP; Brooks MB
J Vet Emerg Crit Care (San Antonio); 2021 Jan; 31(1):18-24. PubMed ID: 33118685
[TBL] [Abstract][Full Text] [Related]
16. Rivaroxaban demonstrates in vitro anticoagulant effects in canine plasma.
Conversy B; Blais MC; Dunn M; Gara-Boivin C; Carioto L; del Castillo JR
Vet J; 2013 Nov; 198(2):437-43. PubMed ID: 24053991
[TBL] [Abstract][Full Text] [Related]
17. Possible Rivaroxaban Failure during the Postpartum Period.
Rudd KM; Winans AR; Panneerselvam N
Pharmacotherapy; 2015 Nov; 35(11):e164-8. PubMed ID: 26598101
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous hemothorax caused by concomitant low-dose rivaroxaban and itraconazole in a 95-year-old patient: case report and literature review.
Liu M; Liu W; Jiao H
J Int Med Res; 2021 Sep; 49(9):3000605211047712. PubMed ID: 34586928
[TBL] [Abstract][Full Text] [Related]
19. Resolution of massive left atrial appendage thrombi with rivaroxaban before balloon mitral commissurotomy in severe mitral stenosis: A case report and literature review.
Li Y; Lin J; Peng C
Medicine (Baltimore); 2016 Dec; 95(49):e5577. PubMed ID: 27930571
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulant therapy with the oral direct factor Xa inhibitors rivaroxaban, apixaban and edoxaban and the thrombin inhibitor dabigatran etexilate in patients with hepatic impairment.
Graff J; Harder S
Clin Pharmacokinet; 2013 Apr; 52(4):243-54. PubMed ID: 23389892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
